I did post their PromarkerD (dedicated) website some months ago & their is HUB Access with login for remote access to results. It’s a brilliant idea & now has TGA approval for IT. It may have been something PIQ were waiting on & we all know these things take some time. Anyway, here is the website (in case you missed it) with PromarkerD access via HUB plus all useful information on the test, types of PromarkerD & I think this is specifically for the ELISA test interpretation (as opposed to mass spectrometry capability & what PIQ have been doing with Jannsen’s blood samples for their ground breaking Invokana (canaglizlofin) Trials in diabetic kidney disease (DKD & CKD) & possibly also contributed to Cardiovascular (CV) Disease & FDA fast tracking for indication which a decision is due around October 2019 (DKD/CKD). PromarkerD was used as a Companion Diagnostic (CDx) in Janssen’s (Johnson & Johnson) clinical trials. Not to say their online capability cannot be used for all PromarkerD testing, but this I thought was a very practical approach to sample analysis, especially for remote testing sites (think regional areas & no convenient access to large laboratories, possibly Third World Health):
Also, patent protection now in Indonesia (6th largest population with diabetes = approx 10 million), Australia, China, Japan, Europe, USA, Russia, Singapore granted & other jurisdictions pending.
How this ANN was not price sensitive, & yet the one recently was is beyond belief! Anyway, it’s obviously flown under the radar, so great for holders who want to top up (That’s you @Eqz lol). I agree with you @wisdomofsilence, the drop in SP is strange on not one, but 2 really good ANNs in the last few days. If the 4C isn’t great, so be it, the company are making up for that in progress & if the spend was big, so should be the R&D rebate.
Waiting on the big one for PromarkerD, USA, but who knows what will come first with all their patent protected IP & GOVT funded health costs & test kits ready to go? It may even be Asia? Best Wishes All,
PIQ Price at posting:
33.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)